Answers are grounded in this paper and cite their sources.
Latency reversing agents (LRAs) such as protein kinase C (PKC) modulators can reduce rebound-competent HIV reservoirs in small animal models. Furthermore, administration of natural killer (NK) cells following LRA treatment improves this reservoir reduction. It is currently unknown why the combination of a PKC modulator and NK cells is so potent and whether exposure to PKC modulators may augment NK cell function in some way.
No takes yet. Share an insight, caveat, or question.
Dimapasoc et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: